Publications Using SART CORS

Publications are listed in chronological order with most recent first.

  1. Walsh TJ, Raheem O, Chen T, Alukal J, Nangia A, Luke B. Impact of male factors on pregnancy outcomes with assisted reproductive technologies. In preparation.
  2. Bocca S, Mahesan A, Luke B, Brown MB, Wantman E, Oehninger S. Risk of congenital malformations in ICSI with surgically obtained sperm: A US study in four States. In preparation.
  3. Luke B, Brown MB, Wantman E, Meyer RE, Foresteri N, Watkins S, Yazdy M, Browne M, Fisher S, Canfield MA, Ethen M, Nichols HB, Oehninger S, Doody K. Risk of blastogenesis birth defects in IVF, non-IVF ART, and fertile births. In preparation.
  4. Park H, Sundaram R, Bell EM, Bell G, Ghassabian A, Lawrence DA, Luke B, Yeung E. Newborn biomarkers on infectious and respiratory diseases during early childhood. In preparation.
  5. Peyser A, Goldman R, Blitz MJ, Vohra N, Bristow S, Leung TM, Lesser M, Hershlag A.  Monozygosity in ART in the United States: Society for Assisted Reproductive Technology (SART) data from 2005-2015.  Submitted for publication.
  6. The effect of trophectoderm biopsy for preimplantation genetic testing on fetal birth weight and preterm delivery.  Sarkar P, New EP, Jindal S, Tanner JP, Imudia AN. Minerva Obstet Gynecol 2023; online ahead of print.
  7. Chu CS, Li Dongmei, Olson-Chen C, Kawwass J, Vitek W.  Recurrence risk and risk factors for monozygotic twin and triplet birth in over 65,000 single-embryo transfers.  J Assist Reprod Genet 2023; 40(4):851-55.
  8. AMH independently predicts aneuploidy but not live birth per transfer in IVF PGT-A cycles.  Li HJ, Seifer DB, Tal R.  Reprod Biol Endocrinol 2023; 21(1): 19.
  9. Kucherov A, Fazzari M, Lieman H, Ball GD, Doody K, Jindal S. PGT-A is associated with reduced cumulative live birth rate in first reported IVF stimulation cycles age ≤40: an analysis of 133,494 autologous cycles reported to SART CORS.  J Assisted Reprod Genet 2023; 40(1): 137-49.
  10. Hurley EG, Sun F, Zhang H, Polotsky AJ, Rios JS.  Minimal stimulation using gonadotropin-releasing hormone antagonist is associated with higher live birth rates: a national study of 13,050 cycles.  Womens Health Rep 2022; 3(1): 957-63.
  11. Hynes JS, Weber JM, Truong T, Acharya KS, Eaton JL. Body mass index is negatively associated with a good perinatal outcome after in vitro fertilization among patients with polycystic ovary syndrome: A national study. FF Rep 2022; 4(1): 77-84.
  12. Rauh-Hain JA, Zubizarreta J, Nitecki R, Melamed A, Fu S, Jorgensen K, Brady PC, Baker VL, Chavez-MacGregor M, Giordano SH, Keating NL.  Survival outcomes following pregnancy or assisted reproductive technologies after breast cancer: a population-based study. Cancer 2022; 128(17):3243-53.
  13. Intracytoplasmic sperm injection vs. conventional in vitro fertilization in patients with non-male factor infertility. Iwamoto A, Van Voorhis BJ, Summers KM, Sparks A, Mancuso AC. Fertil Steril 2022; 118(3):465-72.
  14. George JS, Lee MS, Ashby RK, Goldman R, Ginsburg ES, Lanes A, Srouji SS. The impact of insurance mandates on donor oocyte utilization: an analysis of 39,338 donor oocyte cycles from the Society for Assisted Reproductive Technology registry. Am J Obstet Gynecol 2022; 227(6):877.e1-877.e11.
  15. Carusi DA, Gopal D, Cabral HJ, Racowsky C, Stern JE. A risk factor profile for placenta accreta spectrum in pregnancies conceived with assisted reproductive technology.  FS Reprod 2023; 4(3):279-85.
  16. Carusi DA, Gopal D, Cabral HJ, Bormann CL, Racowsky C, Stern JE.  A unique placenta previa risk factor profile for pregnancies conceived with assisted reproductive technology. Fertil Steril 2022;118(5):894-903.
  17. Bakkensen JB, Flannagan KSJ, Mumford SL, Hutchinson AP, Cheung EO, Moreno PL, Jordan N, Feinberg EC, Goldman KN. A SART data cost-effectiveness analysis of planned oocyte cryopreservation versus in vitro fertilization with preimplantation genetic testing for aneuploidy considering ideal family size. Fertil Steril 2022; 118(5):875-84.
  18. Siegel DR, Grau L, Sammel M, Nel-Themaaat L, Santoro N, Polotsky AJ. Anti-mullerian hormone and follicle-stimulating hormone are poor independent predictors of live birth after assisted reproductive technology. Reprod Sci 2022; 30(4):1316-23.
  19. Farland LV, Stern JE, Hwang SS, Liu CL, Cabral H, Knowlton R, Gershman ST, Coddington CC, Missmer SA. History of cancer and fertility treatment outcomes: a registry linkage study in Massachusetts. J Assist Reprod Genet 2022; 39(2): 517-26.
  20. Li M, Singh B, Baker VL. Association between embryo morphological quality and birth weight for singletons conceived via autologous fresh embryo transfer: an analysis using Society for Assisted Reproductive Technology Clinical Outcomes Reporting System. Li M, Singh B, Baker VL. Fertil Steril 2022; 118(4): 715-23.
  21. Luke B, Brown MB, Wantman E, Schymura MJ, Browne ML, Fisher SC, Forestieri NE, Rao C, Nichols HB, Yazdy MM, Gershman ST, Sacha CR, Williams M, Ethen MK, Canfield MA, Doody KJ, Eisenberg ML, Baker VL, Williams C, Sutcliffe AG, Richard MA, Lupo PJ. The risks of birth defects and childhood cancer with conception by assisted reproductive technology.  Hum Reprod 2022; 37(11):2672-89.
  22. Farland LV, Stern JE, Liu CL, Cabral HJ, Coddington CC, Diop H, Dukhovny D, Hwang S, Missmer SA.  Polycystic ovary syndrome and risk of adverse pregnancy outcomes: a registry linkage study from Massachusetts. Hum Reprod 2022; 37(11):2690-9.
  23. Mejia RB, Capper EA, Summers KM, Mancuso AC, Sparks AE, Van Voorhis BJ. Cumulative live birth rate in women aged <37 years after in vitro fertilization with or without preimplantation genetic testing for aneuploidy: a Society for Assisted Reproductive Technology Clinic Outcome Reporting System retrospective analysis.  FS Rep 2022; 3(3):184-91.
  24. IVF outcomes following ICSI cycles using testicular sperm in obstructive (OA) vs. non-obstructive azoospermia (NOA) and the impact of maternal and paternal age: a SART CORS data registry.  Sadek S, Matitashvili T, Alddin RS, Morshedi B, Ramadan H, Dodani S, Bocca S. J Assist Reprod Genet 2023; 40(3):627-37.
  25. Arkfield C, Han E, Tal R, Seifer DB.  AMH predicts miscarriage in non-PCOS but not in PCOS related infertility ART cycles.  Reprod Biol Endocrinol 2023; 21(1):35.
  26. Bedrick BS, Tipping AD, Nickel KB, Riley JK, Jain T, Jungheim ES.  State-mandated insurance coverage and preimplantation genetic testing (PGT) in the United States.  Obstet Gynecol 2022; 139(4): 500-8.
  27. Tsai S, Chung EH, Truong T, Ferrell AS, Wu J, Ohamadike O, Eaton JL.  Racial and ethnic disparities among donor oocyte banks in the United States. Fertil Steril 2022; 117(3): 622-8.
  28. Acharya KS, Harris BS, Weber JM, Truong T, Pieper C, Eaton JL.  Impact of increasing antimullerian hormone level on in vitro fertilization fresh transfer and live birth rate.  FS Rep; 3(3): 223-30.
  29. Awadwalla MS, Ho JR, McGinnis LK, Ahmady A, Cortessis VK, Paulson RJ.  Embryo morphology and live birth in the United States.  FS Rep 2022; 3(2): 131-7.
  30. Williams RS, Ellis DD, Wilkinson EA, Kramer JM, Datta S, Guzick D.  Factors affecting live birth rates in donor oocytes from commercial egg banks vs. program egg donors: an analysis of 40,485 cycles from the Society for Assisted Reproductive Technology registry in 2016-2018.  Fertil Steril 2022; 117(2): 339-48.
  31. Sarkar P, New EP, Jindal S, New EP, Sprague RG, Tanner JP, Imudia AN. The role of preimplantation genetic testing for aneuploidy in a good prognosis IVF population across different age groups. Syst Biol Reprod Med 2021; 67(5):366-73.
  32. Krishnamoorthy K, Greenberg P, Perlman BE, Morelli SS, Jindal SK, McGovern PG. The incidence of ectopic/heterotopic pregnancies after blastocyst-stage frozen-thawed embryo transfers compared with cleavage stage: a SART CORS study. FS Rep 2021; 2(4):421-7.
  33. Harris BS, Acharya KS, Weber JM, Truong T, Eaton JL.  Can a high AMH mitigate some of the age-related decline in live birth rates?  The association between AMH and live birth among women over age 40 undergoing in vitro fertilization.  FS Rep 2021; 2(4):440-7.
  34. Hwang SS, Dukhovny D, Gopal D, Cabral H, Farland LV, Stern JE. Sex differences in infant health following ART-treated, subfertile, and fertile deliveries. J Assist Reprod Genet 2021; 38(1): 211-8.
  35. Farland LV, Stern JE, Hwang SS, Liu CL, Cabral H, Knowlton R, Gershman ST, Coddington CC, Missmer SA. Early-life cancer, infertility, and risk of adverse pregnancy outcomes: a registry linkage in Massachusetts. Cancer Causes Control 2021; 32(2): 169-80.
  36. Dukhovny D, Hwang S, Gopal D, Cabral H, Diop H, Stern JE. Association of maternal fertility status and fertility treatment with healthcare utilization in infants up to age four. J Perinatol 2021; 41(10): 2408-16.
  37. Stern JE, Liu CL, Cui X, Gopal D, Cabral HJ, Coddington CC, Missmer SA, Hwang S, Farland LV, Dukhovny D, Diop H. Optimizing the control group for evaluating ART outcomes: can outpatient claims data yield a better control group? J Assist Reprod Genet 2021; 38(5): 1089-1100.
  38. Stern JE, Liu CL, Hwang S, Dukhovny D, Farland LV, Coddington CC, Cabral HG. Influence of placental abnormalities and pregnancy induced hypertension in prematurity associated with assisted reproductive technology techniques.  J Clin Med 2021; 10:1681.
  39. Luke B, Brown MB, Ethen MK, Canfield MA, Watkins S, Wantman E, Doody KJ. Sixth grade academic achievement among children conceived with IVF: a population-based study in Texas, USA. J Assist Reprod Genet 2021; 38(6): 1481-92.
  40. Olcha M, Kuokkanen S, Xie X, Negassa A, Pal L, Jindal SK. The impact of Hurricane Katrina, a major natural disaster, on assisted reproductive technology outcomes through an analysis of 451,848 ART cycles.  Sci Rep 2021; 11(1):17864.
  41. Bhatt SJ, Marchetto NM, Roy J, Morelli SS, McGovern PG. Pregnancy outcomes following in vitro fertilization frozen embryo transfer (IVF-FET) with or without preimplantation genetic testing for aneuploidy (PGT-A) in women with recurrent pregnancy loss (RPL): a SART-CORS study.  Hum Reprod 2021; 36(8): 2339-44.
  42. Luke B, Brown MB, Wantman E, Forestieri N, Browne ML, Fisher SC, Yazdy MM, Ethen MK, Canfield MA, Nichols HB, Oehninger S, Doody KJ, Sutcliffe AG, Williams C, Eisenberg ML, Baker VL, Sacha CR, Lupo PJ.  Risks of nonchromosomal birth defects, small-for-gestational-age-birthweight, and prematurity with in vitro fertilization: effect of number of embryos transferred and plurality at conception versus at birth.  J Assist Reprod Genet 2021; 38(4): 835-46.
  43. Katler QS, Shandley LM, Hipp HS, Kawwass JF.  National egg-freezing trends: cycle and patient characteristics with a focus on race/ethnicity.  Fertil Steril 2021; 116(2): 528-37.
  44.  Kawwass JF, Crawford S, Hipp HS.  Frozen eggs: national augologous oocyte thaw outcomes. Fertil Steril 2021; 116(4): 1077-84.
  45. Tal R, Seifer DB, Tal R, Granger E, Tal O.  AMH highly correlates with cumulative live birth rate in women with diminished ovarian reserve independent of age.  J Clin Endocrinol Metab 2021; 106(9): 2754-66.
  46. Kawwaas JF, Ten Eyck P, Sieber P, Hipp HS, Van Voorhis B.  More than the oocyte source, egg donors as patients: a national picture of United States egg donors.  J Assist Reprod Genet 2021; 38(5): 1171-5.
  47. Kotlyar AM, Simsek B, Seifer DB. Disparities in ART live birth and cumulative live birth outcomes for Hispanic and Asian women compared to non-white Hispanic women.  J Clin Med 2021; 10(12): 2615.
  48. Mejia RB, Capper EA, Summers KM, Ten Eyck P, Van Voorhis BJ. Elective transfer of one embryo is associated with a higher cumulative live birth rate and improved perinatal outcomes compared to transfer of two embryos with in vitro fertilization.  FS Rep 2021; 2(1):50-57.
  49. Perlman B, Krishnamoorthy K, Morelli S, Greenberg P, Jindal S, McGovern PG. Increased male live birth rates after blastocyst-stage frozen-thawed embryo transfers compared with cleavage stage: a SART CORS study. FS Rep 2021; 2(2):161-5.
  50. Lee M, Kort J, Baker V. Embryo biopsy and perinatal outcomes of singleton pregnancies: An Analysis of 16,246 frozen embryo transfer cycles reported in the Society for Assisted Reproductive Technology Clinical Outcomes Reporting System. AJOG 2021; doi: 10.1016/j.ajog.2020.10.043.
  51. Makhijani R, Coulter M, Taggar A, Godiwala P, O’Sullivan D, Nulsen J, Engmann L, Benadiva C, Grow D. Reduction in multiple pregnancy rate in donor oocyte-recipient gestational carrier (GC) in vitro fertilization (IVF) cycles in the USA with single embryo transfer and preimplantation genetic testing.  J Assisted Reprod Genet 2021; doi: 10.1007/s10815-021-02112-5.
  52. Sites CK, Bachilova S, Gopal D, Cabral HJ, Coddington CC, Stern JE.  Embryo biopsy and maternal and neonatal outcomes following cryopreserved-thawed single embryo transfer.  Am J Obstet Gynecol 2021; doi: 10.1016/j.ajog.2021.04.235. 
  53. Clark Z, Thakur M, Leach RE, Ireland JJ. FSH dose is negatively correlated with number of oocytes retrieved: analysis of ~650,000 assisted reproductive technology cycles.  J Assist Reprod Genet 2021; doi: 10.1007/s10815-021-02179-0.
  54. Johnston M, Richings NM, Leung A, Sakkas D, Catt C. A major increase in oocyte cryopreservation cycles in the USA, Australia and New Zealand since 2010 is highlighted by younger women but a need for standardized data collection. Hum Reprod 2021; 36(3):624-35.
  55. Ibrahim Y, Stoddard GJ, Johnstone E. A validated prediction score for having two or more embryos for cryopreservation following freeze-all IVF cycles: an analysis utilizing SART CORS database. J Assist Reprod Genet 2021; 38(2):397-405.
  56. Meng F, Goldsammler M, Wantman, E, Buyuk E, Jindal SK. Live birth rate from euploid blastocysts is not associated with infertility etiology or oocyte source following frozen-thawed embryo transfer (FET): analysis of 4,148 cycles reported to SART CORS.  J Assist Reprod Genet 2021; 38(1): 185-92.
  57.  Luke B, Brown MB, Wantman E, Forestieri NE, Browne ML, Fisher SC, Yazdy MM, Ethen MK, Canfield MA, Watkins S, Nichols HB, Farland LV, Oehninger S, Doody KJ, Eisenberg ML, Baker VL.  The risk of birth defects with conception by ART. Hum Reprod 2021; 36(1):116-29.
  58. Coddington CC, Gopal D, Ciu X, Cabral H, Diop H, Stern JE. Influence of subfertility and ART treatment on mortality of women after delivery. Fertil Steril 2020; 113(3): 569-77.
  59. Gerber RS, Fazzari M, Kappy M, Cohen A, Galperin S, Lieman H, Jindal S, Buyuk B. Differential impact of controlled ovarian hyperstimulation on live birth rate in fresh vs. frozen embryo transfer cycles: a SART CORS study, Fertil Steril 2020; 114(6):1225-31.
  60. Roeca C, Johnson R, Truong T, Carlson N, Polotsky AJ. Transfer of fresh versus frozen embryos for donor oocyte recipients. Hum Reprod 2020; 35(12):2850-9.
  61. Luke B, Brown MB, Ethen MK, Canfield MA, Watkins S, Wantman E, Doody KJ. Third grade achievement among children conceived with the use of in vitro fertilization: a population-based study in Texas. Fertil Steril 2020; 113(6): 1242-50.
  62. Cohen A, Kappy M, Fazzari M, Gerber RS, Galperin S, Lieman H, Jindal S, Buyuk E. Length of ovarian stimulation does not impact live birth in fresh donor oocyte cycles: a SART CORS study. J Assist Reprod Genet 2020; 37(12): 3033-8.
  63. Luke B, Brown MB, Eisenberg ML, Callan C, Botting BJ, Pacey A, Sutcliffe AG, Baker VL. In vitro fertilization and risk for hypertensive disorders of pregnancy: associations with treatment parameters.  Am J Obstet Gynecol 2020; 222(4):350.e1-350.e13.
  64. Luke B, Brown MB, Nichols HB, Schymura MJ, Browne ML, Fisher SC, Foriestieri NE, Rao C, Yazdy MM, Gershman ST, Ethen MK, Canfield MA, Williams M, Wantman E, Oehninger S, Doody KJ, Eisenberg ML, Baker VL, Lupo PJ. Assessment of birth defects and cancer risk in children conceived via in vitro fertilization in the US. JAMA Netw Open 2020; 3(10):e2022927.
  65. Seifer DB, Simsek B, Wantman E, Kotlyar AM.  Status of racial disparities between black and white women undergoing assisted reproductive technology in the United States.  Reprod Biol Endocrinol 2020; 18(1):113.
  66. McLaughlin JE, Choi BY, Liu Q, Gelfond JA, Robinson RD, Chang A, Knudtson J.  Does assisted hatching affect live birth in fresh, first in vitro fertilization in good and poor prognosis patients?  J Assisted Reprod Genet 2019; 36(12):2425-33.
  67. Eaton JL, Truong T, Li Y-J Polotsky AJ. Prevalence of a good perinatal outcome with cryopreserved compared with fresh donor oocytes. Obstet Gynecol 135:709-16, 2020.
  68. Shaia KL, Acharya KS, Harris BS, Weber JM, Truong T, Muasher SJ. Total follicle stimulating hormone dose is negatively correlated with live births in a donor/recipient model with fresh transfer: an analysis of 8,627 cycles from the Society for Assisted Reproductive Technology Registry. Fertil Steril 114:545-51, 2020.
  69. Roeca C, Johnson R, Carlson N, Polotsky AJ. Preimplantation genetic testing (PGT) and chances of a healthy livebirth amongst recipients of fresh donor oocytes in the United States: J Assist Reprod Genetics 37:2283-2292, 2020.
  70. Kawwass JF, Shandley LM, Boulet SL, Hipp HS. Oncologic oocyte cryopreservation: national comparison of fertility preservation between women with and without cancer. J Assist Reprod Genetics 37:883-890, 2020.
  71. McGowan R, Pilipenko V, Smolarek TA, West E, Tolusso LK. Aneuploid embryo transfer: clinical policies and provider opinions at United States fertility clinics. Fertil Steril 114:110-117, 2020
  72. Ibrahim Y, Stoddard G, Johnstone E. A clinical counseling tool predicting supernumerary embryos after a fresh IVF cycle. J Assist Reprod Genetics 37:1137-1145, 2020.
  73. Christianson MS, Stern JE, Sun F, Zhang H, Styer AK, Vitek W, Polotsky AJ.  Embryo cryopreservation and utilization in the United States from 2004-2013.  FS Rep 2020; 1(2): 71-77.
  74. Shaia K, Truong T, Pieper C, Steiner A. Pre-implantation genetic testing alters the sex ratio: an analysis of 91,805 embryo transfer cycles. J Assist Reprod Genetics 37:1117-1122, 2020.
  75. Stern JE, Liu CL, Hwang SS, Dukhovny D, Diop H, Cabral H. Contributions to prematurity of maternal health conditions, subfertility, and assisted reproductive technology. Fertil Steril 2020; 114(4): 828-36.
  76. Hwang S, Dukhovny D, Gopal D, Cabral H, Diop H, Coddington CC, Stern JE. Infant health and fresh versus frozen embryo transfer. Fertil Steril 2019; 112(5): 900-907.
  77. Stern JE, Liu CL, Cabral H, Gopal D, Harvey E, Missmer SA, Diop H, Coddington CC. Hospitalization before and after delivery in fertile, subfertile, and ART-treated women. J Assisted Reprod Genet 2019; 36:1989-97.
  78. McLaughlin JE, Choi BY, Liu Q, Gelfond JA, Robinson RD, Chang A, Knudtson J.  Does assisted hatching affect live birth in fresh, first in vitro fertilization in good and poor prognosis patients?  J Assisted Reprod Genet 2019; 36(12):2425-33.
  79. Diop H, Cabral H, Gopal D, Cui X, Stern JE, Kotelchuck M. Early autism spectrum disorders in children born to fertile, subfertile, and ART-treated women. Maternal Child Health J 23:1489-99, 2019.
  80. Smeltzer S, Acharya K, Truong T, Pieper C, Muasher, S. Clinical pregnancy (CP) and live birth (LB) increase significantly with each additional fertilized oocyte up to nine, and CP and LB decline after that: an analysis of 15,803 first fresh in vitro fertilization cycles from the Society for Assisted Reproductive Technology registry. Fertil Steril 112:520-6, 2019.
  81. Quinn MM, Rosen MP, Allen IE, Huddleston HG, Cedars MI, Fujimoto VI. Interpregnancy interval (IPI) and singleton live birth outcomes after frozen embryo transfer. Fertil Steril 111:1145-50, 2019.
  82. Ligon S, Lustik M, Levy G, Pier B. Low antimullerian hormone (AMH) is associated with decreased live birth after in vitro fertilization when follicle stimulating-hormone and AMH are discordant. Fertil Steril 112:73-81, 2019.
  83. Jain T, Grainger DA, Ball GD, Gibbons WE, Rebar RW, Robins JC, Leach RE. 30 years of data: impact of the United States in vitro fertilization data registry on advancing fertility care. Fertil Steril 111:477-88, 2019.
  84. Spector LG, Brown MB, Wantman E, Letterie GS, Toner JP, Doody K, Ginsburg E, Williams M, Koch L, Schymura MJ, Luke B. Association of in vitro fertilization with childhood cancer in the United States. JAMA Pediatrics 173:e190392, 2019.
  85. Luke B, Brown MB, Wantman E, Seifer DB, Sparks AT, Lin PC, Doody KJ, Van Voorhis BJ, Spector LG. Risk of prematurity and infant morbidity and mortality by maternal fertility status and plurality. J Assist Reprod Genetics 36:121-138, 2019.
  86. Hipp HS, Shandley L, Schirmer DA, McKenzie L, Kawwass JF. Oocyte cryopreservation in adolescent women. J Pediatr Adolesc Gynecol 2019; 32(4): 377-82.
  87. Luke B, Brown MB, Wantman E, Baker VL, Doody K, Seifer DB, Spector LG. Risk of severe maternal morbidity by maternal fertility status: A US study in 8 States. Am J Obstet Gynecol 220:195.e1-195.e12, 2019.
  88. Stern JE, Liu CL, Cabral H, Richards EG, Coddington CC, Missmer SA, Diop H. Factors associated with the increased odds of cesarean delivery in ART pregnancies. Fertil Steril 2018; 110(3): 429-36.
  89. Hwang SS, Dukhovny D, Gopal D, Cabral H, Missmer SA, Diop H, Declercq E, Stern JE. Health of infants following ART-treated, subfertile, and fertile deliveries in Massachusetts. Pediatrics 2018; 142(2); e20174069.
  90. Dukhovny D, Hwang SS, Gopal D, Cabral H, Missmer SA, Diop H, Declercq E, Stern JE. Length of stay and cost of birth hospitalization: effects of subfertility and ART. J Perinatol 2018; August: doi.org/10.1038/s41372-018-0205-9.
  91. Stern JE, Liu CL, Cabral HJ, Richards EG, Coddington CC, Dukhovny D, Diop H, Missmer SA. Birth outcomes of singleton vaginal deliveries to ART-treated, subfertile, and fertile primiparous women. J Assist Reprod Genet 2018; 35(9): 1585-93.
  92. Nichols HB, Anderson C, Ruddy K, Black KZ, Luke B, Engel S, Mersereau J. Childbirth after adolescent and young adult cancer: a population-based study. J Cancer Surviv 12:592-600, 2018.
  93. Segal TR, Kim K, Mumford SL, Goldfarb JM, Weinerman RS. How much does the uterus matter? Perinatal outcomes are improved when donor oocyte embryos are transferred to gestational carriers compared to intended parent recipients. Fertil Steril 110:888-895, 2018.
  94. Yu B, Fritz R, Negassa A, Xie X, Jindal S, Vega M, Buyuk E. Use of donor sperm in ART cycles does not affect gestational age or birth weights. Fertil Steril 110:1285-89, 2018.
  95. Seifer DB, Wantman E, Sparks AT, Luke B, Doody KJ, Toner JP, Van Voorhis BJ, Reindollar RH. National survey of the Society for Assisted Reproductive Technology membership regarding insurance coverage for assisted reproductive technologies. Fertil Steril 110:1081-88, 2018.
  96. Luke B, Boulet S, Henningsen AKA. Chapter 3.5. Monitoring long-term outcomes of ART practice: Linking ART surveillance data with other datasets. In Assisted Reproductive Technology Surveillance. Dmitry Kissin, David Adamson, Georgina Chambers (editors). Oxford: Cambridge.
  97. Acharya KS, Acharya CR, Bishop K, Harris B, Raburn D, Muasher SJ. Freezing of all embryos in in vitro fertilization is beneficial in high responders, but not intermediate and low responders: an analysis of 82,935 cycles from the Society for Assisted Reproductive Technology registry. Fertil Steril 110:880-7, 2018.
  98. Vega M, Zaghi S, Buyuk E, Jindal S, Yu B. Comparison of perinatal outcomes following frozen embryo transfer cycles using autologous versus donor oocytes in women 40 to 43 years old: analysis of SART CORS data. J Assist Reprod Genetics 35:2025-9, 2018.
  99. Mahesan AM, Sadek S, Moussavi V, Vazifedan T, Majeed A, Cunningham T, Oehninger S, Bocca S.   Clinical outcomes following ICSI cycles using surgically recovered sperm and the impact of maternal age: 2004-2015 SART CORS registry. J Assist Reprod Genetics, 35:1239-46, 2018.
  100. Nichols HB, Anderson C, Ruddy K, Black KZ, Luke B, Engel S, Mersereau J. Childbirth after adolescent and young adult cancer in North Carolina, 2000-2014. Journal of Cancer Survivorship 12:592-600, 2018.
  101. Amrane S, Lobo R, Brown MB, Luke B. Factors associated with interpregnancy interval among women treated with in vitro fertilization. J Assist Reprod Genetics 35:1595-1602, 2018.
  102. Quinn MM, Rosen MP, Allen IE, Huddleston HG, Cedars MI, Fujimoto VY. Decreased clinical pregnancy and live birth rates from delivery to subsequent assisted reproductive treatment cycle. Human Reprod 33:1316-1321, 2018.
  103. Quinn MM, Rosen MP, Huddleston HG, Cedars MI, Fujimoto VI. Interpregnancy interval (IPI) and singleton live birth outcomes from in vitro fertilization (IVF). Obstet Gynecol 132:115-121, 2018.
  104. Keyhan S, Truong T, Li Y-J, Jackson-Bey T, Eaton J.  Preterm delivery and low birth weights among neonates conceived with Intracytoplasmic Sperm Injection compared with Conventional In Vitro Fertilization. Obstet Gynecol 131:262-268, 2018.
  105. Holden EC, Kashani BN, Morelli SS, Alderson D, Jindal SK, McGovern PG. Improved outcomes after blastocyst stage frozen, thawed embryo transfers compared to cleavage stage: a SART CORS study. Fertil Steril 110:89-94, 2018.
  106. Murugappan G, Farland LV, Missmer SA, Correia KF, Anchan RM, Ginsburg ES. Gestational carrier in Assisted Reproductive Technology. Fertil Steril 109:420-8, 2018.
  107. Tal R, Seifer DB, Wantman E, Baker V, Tal O. Antimullerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society of Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012-2013. Fertil Steril 109:258-265, 2018.
  108. Vega M, Zaghi S, Buyuk E, Jindal S. Are All Twins Monozygotic Following Elective Single Embryo Transfer? Analysis of 32,600 eSET Cycles Reported to SART. Fertil Steril 109:118-122, 2018.
  109. Luke B, Brown MB, Liu CL, Diop H, Stern JE. Validation of severe maternal morbidity on the US certificate of live birth (Research Letter) Epidemiology 29:e31-e32, 2018.
  110. Luke B. Invited Expert Review. Pregnancy and birth outcomes in couples with infertility with and without assisted reproductive technology: With an emphasis on US population-based studies. Am J Obstet Gynecol 217:270-281, 2017.
  111. Mersereau J, Stanhiser J, Coddington C, Jones T, Luke B, Brown MB. Patient and cycle characteristics predicting high pregnancy rates with single embryo transfer: an analysis of the SART outcomes between 2004 and 2013. Fertil Steril 108:750-756, 2017.
  112. Barad DH, Darmon SK, Kushnir VA, Albertini DF, Gleicher N. Impact of preimplantation genetic screening on donor oocyte-recipient cycles in the United States. Am J Obstet Gynecol 217:576.e1-e8, 2017.
  113. Liberman R, Getz KD, Luke B, Stern JE, Declercq ER, Chen X, Anderka M. Assisted Reproductive Technology and Birth Defects: Effects of Subfertility and Multiple Births. Birth Defects 109:1144-1153, 2017.
  114. Stern JE, Gopal D, Diop H, Missmer S, Coddington C, Luke B. Inpatient hospitalizations in women with and without assisted reproductive technology live birth. J Assist Reprod Genetics 34:1043-1049, 2017.
  115. Luke B. Invited Expert Review. Adverse effects of female obesity and interaction with race on reproductive potential. Fertil Steril 107:868-877, 2017.
  116. Luke B, Gopal D, Stern JE, Diop H. Adverse pregnancy, birth, and infant outcomes in twins: Effects of maternal fertility status and infant gender combination. The Massachusetts Outcomes Study of Assisted Reproductive Technology.  Am J Obstet Gynecol 217:330.e1-15, 2017.
  117. Luke B, Gopal D, Stern JE, Diop H. Pregnancy, birth, and infant outcomes by maternal fertility status: The Massachusetts Outcomes Study of Assisted Reproductive Technology. Am J Obstet Gynecol, 217:327.e1-14, 2017.
  118. Luke B, Brown MB, Wantman E, Stern JE, Toner J, Coddington CC. Increased risk of large-for-gestational age birthweight in singleton siblings conceived with in vitro fertilization in frozen versus fresh cycles. J Assist Reprod Genetics 34:191-200, 2017.
  119. Knudtson JF, Failor CM, Gelfond JA, Goros MW, Chang TA, Schenken RS, Robinson RD. Assisted hatching and live births in first-cycle frozen embryo transfers. Fertil Steril 108:628–3, 2017.
  120. Xiong X, Dickey RP, Buekens P, Shaffer J, Pridjian G. Use of Intracytoplasmic Sperm Injection and Birth Outcomes in Women Conceiving Through In Vitro Fertilization. Paediatr Perinat Epidemiol 108-115, 2017.
  121. Shapiro AJ, Darmon SK, Barad DH, Albertini DF, Gleicher N, Kushnir VA. Effect of race and ethnicity on utilization and outcomes of assisted reproductive technology in the USA. Reprod Bio and Endo 15:44, 2017.
  122. Wang ET, Kathiresan ASQ, Bresee C, Greene N, Alexander C, Pisarska MD. Abnormal implantation after fresh and frozen in vitro fertilization cycles. Fertil Steril 107:1153–8, 2017.
  123. Kushnir VA, Darmon SA, Shapiro AJ Albertini DF, Barad DH, Gleicher N. Utilization of third party reproductive technology in the United States. Am J Obstet Gynecol Mar; 216:266.e1-266.e10, 2017.
  124. Dickey RP, Pridjian G, Xiong X, Klempel MC. Birth weight by gestational age for 76,710 twins born in the United States as a result of In Vitro Fertilization: 2006-2010. Am J Perinatology 34: 31-37, 2017.
  125. Provost MP, Thomas SM, Yeh JS, Hurd WH, and Eaton JL. State insurance mandates and multiple birth rates after in vitro fertilization. Obstet Gynecol 128:1205-14, 2016.
  126. Grimstad FW, Nangia AK, Luke B, Stern JE, Mak W. Use of ICSI in IVF cycles in women with tubal ligation does not improve pregnancy or live birth rates. Human Reprod 31:2750-2755, 2016.
  127. Luke B, Gopal D, Cabral H, Diop H, Stern JE. Perinatal outcomes of singleton siblings: The effects of maternal fertility status and ART treatment. J Assist Reprod Genetics 33:1203-13, 2016.
  128. Stern JE, Gopal D, Liberman R, Anderka M, Kotelchuck M, Luke B. Validation of birth outcomes from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System (SART CORS): population-based analysis from Massachusetts Outcome Study of Assisted Reproductive Technology (MOSART). Fertil Steril 106:717-22, 2016.
  129. Dude AM, Yeh JS, Muasher SJ. Donor oocytes are associated with preterm birth when compared to fresh autologous in vitro fertilization cycles in singleton pregnancies. Fertil Steril 106:660-5, 2016.
  130. Keyhan S, Acharya KS, Acharya CR, Yeh SJ, Provost MP, Goldfarb JM, Muasher SJ. How compliant are in vitro fertilization member clinics in following embryo transfer guidelines? An analysis of 59,689 fresh first in vitro fertilization autologous cycles from 2011 to 2012. Fertil Steril 106:645-52, 2016.
  131. Acharya KS, Keyhan S, Acharya CR, Yeh JS, Provost MP, Goldfarb JM, Muasher SJ. Do donor oocytes cycles comply with ARM/SART embryo transfer guidelines? An analysis of 13,393 donor cycles from the SART registry. Fertil Steril 106:603-07, 2016.
  132. Stern JE, McLain AC, Buck Louis GM, Luke B, Yeung EH. Accuracy of self-reported survey data on assisted reproductive technology treatment parameters and reproductive history. Am J Obstet Gynecol 215:219.e1-6, 2016.
  133. Luke B, Brown MB, Spector LG. Validation of Infertility Treatment and Assisted Reproductive Technology Use On the Birth Certificate in Eight States. (Research Letter) Am J Obstet Gynecol 215:126-7, 2016.
  134. Styer AK, Luke B, Christianson MS, Vitek W, Baker V, Armstrong A, Polotsky AJ.  Factors associated with the use of elective single embryo transfer and pregnancy outcomes in the United States 2004-2012. Fertil Steril 106:80-9, 2016.
  135. Seifer DB, Tal O, Wantman E, Edul P, Baker VL. Prognostic indicators of ART outcomes of cycles with ultra-low serum antimüllerian hormone (AMH): a multivariate analysis of over 5000 autologous cycles from the SART CORS database for 2012-2013. Fertil Steril 105:385-93, 2016.
  136. Dickey, RP, Xiong X, Pridjian G, Klempel, MC. Singleton birthweight by gestational age following in vitro fertilization in the United States. Am J Obstet Gynecol 214(1):101.e1-101.e13, 2016.
  137. Toner J, Coddington CC, Doody K, van Voorhis B, Seifer D, Ball GD, Luke B, Wantman E. SART & ART in the US: a 2016 Update. Fertil Steril 106:541-6, 2016.
  138. Luke B, Brown MB, Spector LG, Stern JE, Smith YR, Williams M, Koch L, Schymura MJ. Embryo banking among women diagnosed with cancer: A population-based study in New York, Texas, and Illinois. J Assist Reprod Genetics 33:667-674, 2016.
  139. Luke B, Stern JE, Kotelchuck M, Declercq E, Anderka M, Diop H. Birth outcomes by infertility treatment: Analyses of the Massachusetts Outcomes Study of Assisted Reproductive Technologies (MOSART). J Reprod Med 61:114-127, 2016.
  140. Belanoff C, Declercq ER, Diop H, Gopal D, Kotelchuck M, Luke B, Nguyen T, Stern JE. Severe maternal morbidity and the use of assisted reproductive technology. Obstet Gynecol 127:527-534, 2016.
  141. Diop H, Gopal D, Cabral H, Belanoff C, Declercq ER, Kotelchuck M, Luke B, Stern JE. Assisted reproductive technology and Early Intervention enrollment. Pediatrics 137 (3) e20152007, 2016.
  142. Luke B, Stern JE, Hornstein MD, Kotelchuck M, Diop H, Cabral H, Declercq ER. Is the wrong question being asked in infertility research? J Assist Reprod Genetics 33:3-8, 2016.
  143. Luke B, Brown MB, Missmer SA, Spector LG, Leach RE, Williams M, Koch L, Smith YR, Stern JE, Ball GD, Schymura MJ. Assisted reproductive technology use and outcomes among women with a history of cancer. Human Reprod 31:183-9, 2016.
  144. Luke B, Stern JE, Kotelchuck M, Declercq E, Cohen B, Diop H. Birth outcomes by infertility diagnosis: Analyses of the Massachusetts Outcomes Study of Assisted Reproductive Technologies (MOSART). J Reprod Med 60:480-490, 2015.
  145. Luke B, Brown MB, Spector LG, Missmer SA, Leach RE, Williams M, Koch L, Smith Y, Stern JE, Ball GD, Schymura MJ. Cancer in women after assisted reproductive technology. Fertil Steril 104:1218-26, 2015.
  146. Declercq ER, Luke B, Stern JE, Diop H, Gopal D, Cabral H, Belanoff C, Kotelchuck M. Maternal Postpartum Hospitalization Following ART Births (Research letter) Epidemiology 26:e64-65, 2015.
  147. Luke B, Stern JE, Kotelchuck M, Declercq ER, Hornstein MD, Gopal D, Hoang L, Diop H. Adverse pregnancy outcomes after in vitro fertilization: Effect of number of embryos transferred and plurality at conception. Fertil Steril 104:79-86, 2015.
  148. Buck Louis GM, Druschel C, Bell E, Stern JE, Luke B, McLain A, Sundaram R, Yeung E. Use of assisted reproductive technology treatment as reported by mothers in comparison with registry data: the Upstate KIDS Study. Fertil Steril 103:1461-8, 2015.
  149. Stern JE, Luke B, Tobias M, Gopal D, Hornstein MD, Diop H. Adverse pregnancy and birth outcomes by infertility diagnoses with and without ART treatment. Fertil Steril 103:1438-45, 2015.
  150. Baker VL, Brown MB, Luke B, Smith GW, Ireland JJ. Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles. Fertil Steril 104:1145-52.e1-5, 2015.
  151. Declercq E, Luke B, Belanoff C, Cabral H, Diop H, Gopal D, Hoang L, Kotelchuck M, Stern JE, Hornstein MD. Perinatal outcomes associated with assisted reproductive technology: The Massachusetts outcomes study of assisted reproductive technologies (MOSART). Fertil Steril 103:888-95, 2015.
  152. Luke B, Brown MB, Wantman E, Stern JE, Baker VL, Widra E, Coddington CC 3rd, Gibbons WE, Van Voorhis BJ, Ball, GD. Application of a validated prediction model for in vitro fertilization: Comparison of live birth rates and multiple birth rates with one embryo transferred over two cycles versus two embryos in one cycle. Am J Obstet Gynecol 212:676.e1-7, 2015.
  153. Baker VL, Brown MB, Luke B, Conrad KP. Association of number of retrieved oocytes with live birth rate and birth weight: an analysis of 231,815 cycles of in vitro fertilization. Fertil Steril 103:931-938, 2015.
  154. Fechner AJ, Brown KR, Onwubalili N, Jindal SK, Weiss G, Goldsmith LT, McGovern PG. Effect of single embryo transfer on the risk of preterm birth associated with in vitro fertilization. J Assist Reprod Genetics 32:221-4, 2015.
  155. Xiong X, Dickey RP, Pridjian G Buekens P. Maternal age and preterm births in singleton and twin pregnancies conceived by in vitro fertilization in the United States. Paediatr Perinat Epidemiol 29:22-30, 2015.
  156. Pal L, Kidwai N, Kayani J, Grant WB. Donor egg IVF model to assess ecological implications for ART success. J Assist Reprod Genet 31:1453-60, 2014.
  157. Liberman RF, Stern JE, Luke B, Reefhuis J, Anderka M. Validating assisted reproductive technology self-report. Epidemiology 25:773-5, 2014.
  158. Butts SF, Owen C, Mainigi M, Senapati S, Seifer DB, Dokras A. Assisted hatching and intracytoplasmic sperm injection are not associated with improved outcomes in assisted reproduction cycles for diminished ovarian reserve: an analysis of cycles in the United States from 2004 to 2011. Fertil Steril 102:1041-1047, 2014.
  159. Luke B, Brown MB, Wantman E, Stern JE, Baker VL, Widra E, Coddington CC 3rd, Gibbons WE, Ball GD. A prediction model for live birth and multiple births within the first three cycles of assisted reproductive technology. Fertil Steril 102:744-52, 2014.
  160. Yeh JS, Steward RG, Dude AM, Shah AA, Goldfarb JM, Muasher SJ. Pregnancy rates in donor oocyte cycles compared to similar autologous in vitro fertilization cycles: an analysis of 26,457 fresh cycles from the Society for Assisted Reproductive Technology. Fertil Steril 102:399-404, 2014.
  161. Stern JE, Luke B, Hornstein MD, Cabral H, Gopal D, Diop H, Kotelchuck M. The effect of father's age in fertile, subfertile, and assisted reproductive technology pregnancies: A population-based cohort study. J Assist Reprod Genet 31:1437-44, 2014.
  162. Gee RE, Dickey RP, Xiong X, Clark LS, Pridjian G. Impact of monozygotic twinning on multiple births resulting from in vitro fertilization in the United States, 2006-2010. Am J Obstet Gynecol 210:468.e1-6, 2014.
  163. Luke B, Brown MB, Stern JE, Jindal SK, Racowsky C, Ball GD. Using the Society for Assisted Reproductive Technology Clinic Outcome System morphological measures to predict live birth after assisted reproductive technology. Fertil Steril 102:1338-44, 2014.
  164. Yeh JS, Steward RG, Dude AM, Shah AA, Goldfarb JM, Muasher SJ. Pregnancy outcomes decline in recipients over age 44: an analysis of 27,959 fresh donor oocyte in vitro fertilization cycles from the Society for Assisted Reproductive Technology. Fertil Steril 101:1331-6, 2014.
  165. Liberman RF, Stern JE, Luke B, Reefhuis J, Anderka M. Maternal Self-Report of Assisted Reproductive Technology Use in the National Birth Defects Prevention Study: Validation using fertility clinic data. Epidemiology 25:773-5 2014.
  166. Stern JE, Kotelchuck M, Luke B, Declercq E, Cabral H, Diop H. Calculating length of gestation from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System (SART CORS) database versus vital records may alter reported rates of prematurity. Fertil Steril 101:1315-20, 2014.
  167. Kotelchuck M, Hoang L, Stern JE, Diop H, Belanoff C, Declercq E. The MOSART Database: Linking the SART CORS Clinical Database to the Population-Based Massachusetts PELL Reproductive Public Health Data System. Matern Child Health J 18:2167-78, 2014
  168. Steward RG, Lan L, Shah AA, Yeh JS, Price TM, Goldfarb JM, Muasher SJ. Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles. Fertil Steril 101:967-73, 2014.
  169. Luke B, Brown MB, Wantman E, Stern JE. Factors associated with monozygosity in assisted reproductive technology pregnancies and the risk of recurrence using linked cycles. Fertil Steril 101:683-9, 2014.
  170. Marshall SM, Onwubalili N, Brown K, Jindal SK, McGovern PG. Blastocyst expansion score and trophectoderm morphology strongly predict successful clinical pregnancy and live birth following elective single embryo blastocyst transfer (SET): A national study. J Assist Reprod Genetics 30:1577-81, 2013.
  171. Declercq ER, Belanoff C, Diop H, Gopal D, Hornstein MD, Kotelchuck M, Luke B, Stern JE. Identifying women with indicators of subfertility in a statewide population database: Operationalizing the missing link in ART research. Fertil Steril 101:463-71 2014.
  172. Luke B, Brown MB, Wantman E, Baker VL, Grow DR, Stern JE. Second try: who returns for additional ART treatment and the effect of a prior ART birth. Fertil Steril 100:1580-4, 2013.
  173. Gordon JD, Dimattina M, Reh A, Botes A, Celia G, Payson M. Utilization and success rates of unstimulated in vitro fertilization in the United States: an analysis of the Society for Assisted Reproductive Technology database. Fertil Steril 100:392-5, 2013.
  174. Butts SF, Ratcliffe S, Dokras A, Seifer DB. Diagnosis and treatment of diminished ovarian reserve in assisted reproductive technology cycles of women up to age 40 years: the role of insurance mandates. Fertil Steril 99:382-8, 2013.
  175. Xiong X, Pridjian G, Dickey RP. Racial and ethnic disparities in preterm births in infants conceived by in vitro fertilization in the United States. Am J Obstet Gynecol 209:128.e1-6, 2013.
  176. Dickey RP, Xiong X, Xie Y, Gee RE, Pridjian G. Effect of maternal height and weight on risk for preterm singleton and twin births resulting from IVF in the United States, 2008-2010. Am J Obstet Gynecol 209:349.e1-6, 2013.
  177. Stern JE, Brown MB, Wantman E, Kalra SK, Luke B. Live birth rates and birth outcomes by diagnosis using linked cycles from the SART CORS database. J Assist Reprod Genet 30:1445-50, 2013. 
  178. Wellons MF, Fujimoto VY, Baker VL, Barrington DS, Broomfield D, Catherino WH, Richard-Davis G, Ryan M, Thornton K, Armstrong AY. Race matters: a systematic review of racial/ethnic disparity in Society for Assisted Reproductive Technology reported outcomes. Fertil Steril 98:406-9, 2012.
  179. Kalra SK, Ratcliffe SJ, Barnhart KT, Coutifaris C. Extended embryo culture and an increased risk of preterm delivery. Obstet Gynecol 120:69-75, 2012.
  180. Luke B, Brown MB, Wantman E, Lederman A, Gibbons W, Schattman GL, Lobo RA, Leach RE, Stern JE. Cumulative birth rates with linked assisted reproductive technology cycles. N Engl J Med 366:2483-91, 2012.
  181. Stern JE, Lieberman ES, Macaluso M, Racowsky C. Is cryopreservation of embryos a legitimate surrogate marker of embryo quality in studies of assisted reproductive technology conducted using national databases? Fertil Steril 97:890-3, 2012.
  182. Stern JE, Hickman TN, Kinzer D, Penzias AS, Ball GD, Gibbons WE. Can the Society for Assisted Reproductive Technology Clinic Outcome Reporting System (SART CORS) be used to accurately report clinic total reproductive potential (TRP)? Fertil Steril 97:886-9, 2012.
  183. Dickey RP, Xiong X, Gee RE, Pridjian G. Effect of maternal height and weight on risk of preterm birth in singleton and twin births resulting from in vitro fertilization: a retrospective cohort study using the Society for Assisted Reproductive Technology Clinic Outcome Reporting System. Fertil Steril 97:349-54, 2012.
  184. Calhoun KC, Fritz MA, Steiner AZ. Examining the relationship between ovarian reserve, as measured by basal FSH levels, and the risk of poor obstetric outcome in singleton IVF gestations. Hum Reprod 26:3424-30, 2011.
  185. Kalra SK, Ratcliffe SJ, Coutifaris C, Molinaro T, Barnhart KT. Ovarian stimulation and low birthweight in newborns conceived through in vitro fertilization. Obstet Gynecol 118:863-71, 2011.
  186. Ginsburg ES, Baker VL, Racowsky C, Wantman E, Goldfarb J, Stern JE. Use of preimplantation genetic diagnosis and preimplantation genetic screening in the United States: a Society for Assisted Reproductive Technology Writing Group paper. Fertil Steril 96:865-8, 2011.
  187. Luke, B, Brown, MB, Missmer, SA, Bukulmez, O, Leach, R, Stern JE. The effect of increasing obesity on the response to and outcome of assisted reproductive technology: a national study. Fertil Steril 96:820-5, 2011.
  188. Nangia AK, Luke B, Megid WA, Smith J, Mak W, Stern JE. National study of factors influencing assisted reproductive technology (ART) outcomes with male factor infertility. Fertil Steril 96:609-14, 2011.
  189. Vernon M, Stern JE, Ball GD, Wininger D, Mayer J, Racowsky C. Utility of the national embryo morphology data collection by SART: Correlation between day 3 morphology grade and live birth outcome. Fertil Steril 30;95:2761-3, 2011.
  190. Racowsky C, Stern JE, Gibbons WE, Behr B, Pomeroy KO, Biggers JD. National collection of embryo morphology data into Society for Assisted Reproductive Technology Clinic Outcomes Reporting System: associations among day 3 cell number, fragmentation and blastomere asymmetry, and live birth rate. Fertil Steril 95:1985-9, 2011.
  191. Luke B, Brown MB, Stern JE, Missmer SA, Fujimoto VY, Leach R. Racial and ethnic disparities in assisted reproductive technology (ART) pregnancy and live birth rates within body mass index (BMI) categories. Fertil Steril 95:1661-6, 2011.
  192. Gibbons WE, Cedars M, Ness R. Toward Understanding Obstetrical Outcome in Advanced Assisted Reproduction (ART): Varying Sperm, Oocyte, and Uterine Source And Diagnosis. Fertil Steril 95:1645-9.e1, 2011.
  193. Stern JE, Brown MB, Luke B, Wantman E, Lederman A, Hornstein MD. Cycle 1 as predictor of assisted reproductive technology treatment outcome over multiple cycles: an analysis of linked cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System online database. Fertil Steril 95:600-5, 2011.
  194. Luke B, Brown MB, Stern JE, Missmer SA, Fujimoto VY, Leach R. Female obesity adversely affects assisted reproductive technology (ART) pregnancy and live birth rates. Hum Reprod 26:245-52, 2011.
  195. Luke B, Brown MB, Stern JE, Grainger DA, Klein N, Cedars M. Effect of embryo transfer number on singleton and twin implantation pregnancy outcomes after assisted reproductive technology (ART). J Reprod Med 55:387-394, 2010.
  196. Racowsky, C, Vernon, M, Meyer, J, Ball, GD, Behr, B, Pomeroy, KO, Wininger, D, Gibbons, W, Conaghan, J, Stern, JE. Standardization of Grading Embryo Morphology. J Assist Reprod Genet 27:437-9, 2010.
  197. Baker VL, Luke B, Brown MB, Alvero R, Frattarelli JL, Usadi R, Grainger DA, Armstrong AY. Multivariate analysis of factors affecting probability of pregnancy and live birth with in vitro fertilization: An analysis of the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System. Fertil Steril 94: 1410-16, 2010.
  198. Luke, B, Brown, MB, Morbeck, DE, Hudson, SB, Coddington III, CC, Stern JE. Factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcome. Fertil Steril 94:1399-404, 2010.
  199. Stern, JE, Brown MB, Luke, B, Wantman, E, Lederman, A, Missmer, SA, Hormstein, MD. Calculating Cumulative Live Birth Rates from Linked Cycles of Assisted Reproductive Technology (ART): Data from the Massachusetts SART CORS. Fertil Steril 94:1334-40, 2010.
  200. Racowsky, C, Vernon, M, Meyer, J, Ball, GD, Behr, B, Pomeroy, KO, Wininger, D, Gibbons, W, Conaghan, J, Stern, JE. Standardization of Grading Embryo Morphology. Fertil Steril 94:1152-3, 2010.
  201. Seifer, DB, Zackula,R, Grainger, D. Trends of Racial Disparities in Assisted Reproductive Technologies Outcomes in Black Women Compared with White Women: SART 1999-2000 versus 2004-2006. Fertil Steril 93:626-35, 2010.
  202. Luke B, Brown MB, Grainger DA, Cedars M, Klein N, Stern JE. Practice patterns and outcomes with the use of single embryo transfer in the United States. Fertil Steril 93:490-8, 2010.
  203. Fujimoto VY, Luke B, Brown MB, Jain T, Armstrong A, Grainger DA, Hornstein M. Racial and Ethnic Disparities in Assisted Reproductive Technology (ART) Outcomes in the United States. Fertil Steril 93:382-90, 2010.
  204. Luke B, Brown MB, Grainger DA, Baker VL, Ginsburg E, Stern JE. The sex ratio of singleton offspring in assisted conception pregnancies. Fertil Steril 92:1579-85, 2009.
  205. Luke B, Brown MB, Grainger DA, Stern JE, Klein N, Cedars MI. The effect of early fetal losses on twin assisted conception pregnancy outcomes. Fertil Steril 91:2586-92, 2009.
  206. Luke B, Brown MB, Grainger DA, Stern JE, Klein N, Cedars MI. The effect of early fetal losses on singleton assisted conception pregnancy outcomes. Fertil Steril 91:2578-85, 2009.
  207. Stern JE, Goldman MB, Hatasaka H, MacKenzie TA, Surrey ES, Racowsky C. Optimizing the number of cleavage stage embryos to transfer on day 3 in women 38 years of age and older: a Society for Assisted Reproductive Technology database study. Fertil Steril 91:767-76, 2009.
  208. Stern JE, Goldman MB, Hatasaka H, MacKenzie TA, Racowsky C, Surrey ES. Optimizing the number of blastocyst stage embryos to transfer on day 5 or 6 in women 38 years of age and older: a Society for Assisted Reproductive Technology database study. Fertil Steril 91:157-66, 2009.
  209. Seifer DB, Frazier LM, Grainger DA. Disparity in assisted reproductive technologies outcomes in black women compared with white women. Fertil Steril 90:1701-10, 2008.
  210. Gibbons W, Grainger D, Cedars M, Jain T, Klein N, Stern J. Continuous quality improvement and assisted reproductive technology multiple gestations: some progress, some answers, more questions. Fertil Steril 88:301-4, 2007.
  211. Stern JE, Cedars MI, Jain T, Klein NA, Beaird CM, Grainger DA, Gibbons WE. Assisted reproductive technology practice patterns and the impact of embryo transfer guidelines in the United States. Fertil Steril 88:275-82, 2007. 
     
FAQs

FAQs

Have questions about IVF and infertility? We have answers.
Find A Clinic

Find A Clinic

National statistics from SART member clinics that reported their data through SART.